ask="17.00"
ask_size="100"
average_daily_volume="166144"
bid="4.15"
bid_size="100"
book_value="7.07"
change="-0.06"
change_from_200_day_moving_average="6.46"
change_from_50_day_moving_average="1.40"
change_from_52_week_high="-0.13"
change_From_52_week_low="3.62"
change_in_percent="-0.61%"
close="9.72"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="-15.57M"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="7983000"
high="9.82"
high_52_weeks="9.85"
last_trade_date="2/2/2017"
last_trade_price="9.72"
last_trade_size="200"
last_trade_time="4:00pm"
low="9.59"
low_52_weeks="6.10"
market_capitalization="102.69M"
moving_average_200_day="3.26"
moving_average_50_day="8.32"
name="Novelion Therapeutics Inc. "
notes="N/A"
one_year_target_price="13.62"
open="9.75"
pe_ratio="N/A"
peg_ratio="0.14"
percent_change_from_200_day_moving_average="+198.05%"
percent_change_from_50_day_moving_average="+16.89%"
percent_change_from_52_week_high="-1.32%"
percent_change_from_52_week_low="+59.34%"
previous_close="9.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.38"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="10565000"
short_ratio="13.10"
stock_exchange="NMS"
symbol="NVLN"
volume="43503"
weeks_range_52="6.10 - 9.85"
